Effects of Osteopathic Visceral Manipulation on the Autonomic Nervous System, Balance and Gastrointestinal Disturbances in Individuals With Parkinson's Disease
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05047796 |
Recruitment Status :
Completed
First Posted : September 17, 2021
Last Update Posted : March 13, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Parkinson Disease | Other: Intervention Protocol Other: Sham Protocol | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 14 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Masking Description: | Each participant will be randomly assigned to the intervention group or placebo group by an independent study evaluator. Data will be secretly allocated through sealed, opaque envelopes. After the randomization process, the participant will be evaluated by a researcher who will not have knowledge about the distribution of the groups. |
Primary Purpose: | Treatment |
Official Title: | Effects of Osteopathic Visceral Manipulation on the Autonomic Nervous System, Balance and Gastrointestinal Disturbances in Individuals With Parkinson's Disease: a Randomized Clinical Trial |
Actual Study Start Date : | September 15, 2021 |
Actual Primary Completion Date : | October 5, 2021 |
Actual Study Completion Date : | October 30, 2021 |
Arm | Intervention/treatment |
---|---|
Experimental: Intervention Protocol
Visceral osteopathic techniques
|
Other: Intervention Protocol
The intervention protocol will consist of visceral osteopathic techniques and will be performed by a professional who has 17 years of clinical experience in the field of Osteopathy. |
Sham Comparator: Sham Protocol
Simulated visceral osteopathic techniques
|
Other: Sham Protocol
The sham protocol will be performed by a professional who has 17 years of clinical experience in the field of Osteopathy. The sham protocol will consist of simulation of therapy, where the therapist will place his hands in the same regions of the intervention protocol, without therapeutic intent |
- Change in heart rate variability [ Time Frame: T0= before the protocol (15 minutes); T1= until 48 hours after the end protocol (15 minutes) ]For the analysis, frequency domain indices (LF, HF, LF/HF), time domain (SDNN, RMSSD) and geometric indices will be used
- Change in balance [ Time Frame: T0= before the protocol; T1= until 48 hours after the end protocol ]For balance analysis we will use the Berg balance scale, validated for the Brazilian population. The overall score is 56 points. A score from 0 to 20 represents impairment of balance, 21 to 40 is acceptable balance, and 41-56 is good balance.
- Change in plantar pressure [ Time Frame: T0= before the protocol; T1= until 48 hours after the end protocol ]The static plantar pressure profile will be obtained through pressure sensors present in the platform
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Clinical diagnosis of Parkinson's;
- Not having cardiorespiratory diseases;
- Not being a smoker;
- Do not use alcoholic beverages;
- No cognitive deficit;
- No osteoarticular deformities, plantar ulcers, total or partial amputation of the feet;
- They do not need auxiliary devices for walking
Exclusion Criteria:
- Data from individuals with a series of heart rate intervals with less than 95% of sinus beats will be excluded from the study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05047796
Brazil | |
Anne Kastelianne | |
Presidente Prudente, São Paulo, Brazil |
Responsible Party: | Instituto Docusse de Osteopatia e Terapia Manual |
ClinicalTrials.gov Identifier: | NCT05047796 |
Other Study ID Numbers: |
18945219.4.0000.5402 |
First Posted: | September 17, 2021 Key Record Dates |
Last Update Posted: | March 13, 2024 |
Last Verified: | March 2024 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | The data will be shared for any researcher that requests the data by electronic address |
Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) |
Time Frame: | After one year of publication |
Access Criteria: | To receive the data, the researcher must have sent a request to nupi@idot.com.br |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Parkinson |
Parkinson Disease Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Movement Disorders Synucleinopathies Neurodegenerative Diseases |